Differential pathogenicity of SHIVSF162 P4 infection in pig-tailed and rhesus macaques

Journal of Medical Primatology

Volumn 37, Issue SUPPL. 2, 2008, Pages 13-23

  Polacino, Patricia ^a   Larsen, Kay ^a   Galmin, Lindsey ^b   Suschak, John ^b   Kraft, Zane ^c   Stamatatos, Leonidas ^a,c   Anderson, David ^a   Barnett, Susan W ^d   Pal, Ranajit ^b   Bost, Kristen ^e   Bandivdekar, A H ^f   Miller, Christopher J ^e   Hu, Shiu Lok ^a,g  

^a UNIVERSITY OF WASHINGTON   (United States)

^b ADVANCED BIOSCIENCE LABORATORIES INC   (United States)

^c SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^d Novartis Vaccines and Diagnostics   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f NATIONAL INSTITUTE FOR RESEARCH IN REPRODUCTIVE HEALTH   (India)

^g NONE   (United States)

Author keywords

AIDS vaccine; Intrarectal; Intravaginal; Intravenous; Plasma viremia

Indexed keywords

CHEMOKINE RECEPTOR CCR5;

ANIMAL EXPERIMENT; CD4 LYMPHOCYTE COUNT; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE PREDISPOSITION; IMMUNOPATHOGENESIS; IN VIVO STUDY; MACACA; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RETROVIRUS INFECTION; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; SPECIES DIFFERENCE; T CELL DEPLETION; VIREMIA; VIRUS INFECTIVITY; VIRUS LOAD; VIRUS PATHOGENESIS;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; IMMUNOPHENOTYPING; MACACA MULATTA; MACACA NEMESTRINA; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; SPECIES SPECIFICITY; VIREMIA;

LENTIVIRUS; MACACA MULATTA; MACACA NEMESTRINA; PRIMATES; SUIDAE;

EID: 59149101887     PISSN: 00472565     EISSN: 16000684     Source Type: Journal    
DOI: 10.1111/j.1600-0684.2008.00325.x     Document Type: Conference Paper

References (59)

1. Ambrose Z, Larsen K, Thompson J, Stevens Y, Finn E, Hu S-L, Bosch ML: Evidence for early local viral replication and local production of antiviral immunity upon mucosal simian-human immunodeficiency virus SHIV89.6 infection in Macaca nemestrina. J Virol 2001; 75:8589-96.
2. Barnett SW, Srivastava IK, Kan E, Zhou F, Goodsell A, Cristillo AD, Ferrai MG, Weiss DE, Letvin NL, Montefiori D, Pal R, Vajdy M: Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope. AIDS 2008; 22:339-48.
3. Barry AP, Silvestri G, Safrit JT, Sumpter B, Kozyr N, McClure HM, Staprans SI, Feinberg MB: Depletion of CD8+ Cells in sooty Mangabey monkeys naturally infected with simian immunodeficiency virus reveals limited role for immune control of virus replication in a natural host species. J Immunol 2007; 178:8002-12.
4. Bontrop RE, Watkins DI: MHC polymorphism: AIDS susceptibility in non-human primates. Trends Immunol 2005; 26:227-33.
5. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, Kazzaz Z, Bornstein E, Lambotte O, Altmann D, Blazar BR, Rodriguez B, Teixeira-Johnson L, Landay A, Martin JN, Hecht FM, Picker LJ, Lederman MM, Deeks SG, Douek DC: Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2007; 12:1365-71.
6. Brennan G, Kozyrev Y, Kodama T, Hu S-L: Novel TRIM5 isoforms expressed by Macaca nemestrina. J Virol 2007; 81:12210-7.
7. Buch SJ, Villinger F, Pinson D, Hou Y, Adany I, Li Z, Dalal R, Raghavan R, Kumar A, Narayan O: Innate differences between simian-human immunodeficiency virus (SHIV)KU-2-infected rhesus and pig-tailed macaques in development of neurological disease. Virology 2002; 295:54-62.
8. Buckner C, Gines LG, Saunders CJ, Vojtech L, Srivastava I, Gettie A, Bohm R, Blanchard J, Barnett SW, Safrit JT, Stamatatos L: Priming B cell-mediated anti-HIV envelope responses by vaccination allows for the long-term control of infection in macaques exposed to a R5-tropic SHIV. Virology 2004; 320:167-80.
9. Burke B, Derby NR, Kraft Z, Saunders CJ, Dai C, Llewellyn N, Zharkikh I, Vojtech L, Zhu T, Srivastava IK: Viral evolution in macaques coinfected with CCR5- and CXCR4-tropic SHIVs in the presence or absence of vaccine-elicited anti-CCR5 SHIV neutralizing antibodies. Virology 2006; 355:138-51.
10. Carrington M, O'Brien SJ: The influence of HLA genotype on AIDS. Ann Rev Med 2003; 54:535-51.
11. Castro BA, Nepomuceno M, Lerche NW, Eichberg J, Levy JA: Persistent infection of baboons and rhesus monkeys with different strains of HIV-2. Virology 1991; 184:219-26.
12. Chen Z, Huang Y, Zhao X, Skulsky E, Lin D, Ip J, Gettie A, Ho DD: Enhanced infectivity of an R5-Tropic simian/human immunodeficiency virus carrying human immunodeficiency virus type 1 subtype C envelope after serial passages in pig-tailed macaques (Macaca nemestrina). J Virol 2000; 74:6501-10.
13. Cherpelis S, Jin X, Gettie A, Ho DD, Barnett SW, Shrivastava I, Stamatatos L: DNA-immunization with a V2 deleted HIV-1 envelope elicits protective antibodies in macaques. Immunol Lett 2001; 79:47-55.
14. Derby NR, Kraft Z, Kan E, Crooks ET, Barnett SW, Srivastava IK, Binley JM, Stamatatos L: Antibody responses elicited in macaques immunized with human immunodeficiency virus type 1 (HIV-1) SF162-derived gp140 envelope immunogens: Comparison with those elicited during homologous simian/ human immunodeficiency virus SHIVSF162P4 and heterologous HIV-1 Infection. J Virol 2006; 80:8745-62.
15. Doria-Rose NA, Ohlen C, Polacino P, Pierce CC, Hensel MT, Kuller L, Mulvania T, Anderson D, Greenberg PD, Hu S-L, Haigwood NL: Multigene DNA priming-boosting vaccines protect macaques from acute CD4+-T-cell depletion after simian-human immunodeficiency virus SHIV89.6P mucosal challenge. J Virol 2003; 77:11563-77.
16. Dormont D, Livartowski J, Chamaret S, Guetard D, Henin D, Levagueresse R, van de Moortelle PF, Larke B, Gourmelon P, Vazeux R: HIV-2 in rhesus monkeys: Serological, virological and clinical results. Intervirology 1989; 30:59-65.
17. Endo Y, Igarashi T, Nishimura Y, Buckler C, Buckler-White A, Plishka R, Dimitrov DS, Martin MA: Short- and long-term clinical outcomes in rhesus monkeys inoculated with a highly pathogenic chimeric simian/human immunodeficiency virus. J Virol 2000; 74:6935-45.
18. Estes JD, Gordon SN, Zeng M, Chahroudi AM, Dunham RM, Staprans SI, Reilly CS, Silvestri G, Haase AT: Early resolution of acute immune activation and induction of PD-1 in SIV-infected sooty mangabeys distinguishes nonpathogenic from pathogenic infection in rhesus macaques. J Immunol 2008; 180:6798-807.
19. Fernandez CS, Stratov I, De Rose R, Walsh K, Dal CJe, Smith MZ, Agy MB, Hu S-L, Krebs K, Watkins DI, O'Connor DH, Davenport MP, Kent SJ: Rapid viral escape at an immunodominant simian-human immunodeficiency virus cytotoxic T-lymphocyte epitope exacts a dramatic fitness cost. J Virol 2005; 79:5721-31.
20. Footen J. Classification and distribution of living macaques. In: The Macaques: Studies in Ecology, Behavior, and Evolution. Lindburg (ed.). New York: Van Nostrand-Reinhold, 1980;1-9.
21. Greenier JL, Miller CJ, Lu D, Dailey PJ, Lu FX, Kunstman KJ, Wolinsky SM, Marthas ML. Route of simian immunodeficiency virus inoculation determines the complexity but not the identity of viral variant populations that infect rhesus macaques. J Virol 2001; 75:3753-3765.
22. Gordon SN, Klatt NR, Bosinger SE, Brenchley JM, Milush JM, Engram JC, Dunham RM, Paiardini M, Klucking S, Danesh A, Strobert EA, Apetrei C, Pandrea IV, Kelvin D, Douek DC, Staprans SI, Sodora DL, Silvestri G: Severe depletion of mucosal CD4+ T cells in AIDS-free simian immunodeficiency virus-infected sooty mangabeys. J Immunol 2007; 179:3026-34.
23. Goulder PJR, Watkins DI: Impact of MHC class I diversity on immune control of immunodeficiency virus replication. Nat Rev Immunol 2008; 8:619-30.
24. Haigwood NL: Predictive value of primate models for AIDS. AIDS Rev 2004; 6:187-98.
25. Harouse JM, Gettie A, Tan RC, Blanchard J, Cheng-Mayer C: Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs. Science 1999; 284:816-9.
26. Hirsch VM, Dapolito G, Johnson PR, Elkins WR, London WT, Montali RJ, Goldstein S, Brown C: Induction of AIDS by simian immunodeficiency virus from an African green monkey: Species-specific variation in pathogenicity correlates with the extent of in vivo replication. J Virol 1995; 69:955-67.
27. Hu S-L: Non-human primate models for AIDS vaccine research. Curr Drug Targets Infect Disord 2005; 5:193-201.
28. Hu S-L, Klaniecki JE, Travis BM, Wrey T, Pennathur S, Montefiori DC, Thompson JL, Agy MB, Kuller L, Morton WR: Immunization with HIV-1 gp160 by the "prime and boost" regimen protects macaques against SHIV HXBc2 challenge. In: Vaccines 97. Brown, Burton, Doherty, Mekalanos & Norrby (eds). Cold Spring Harbor, New York: Cold Spring Harbor Laboratory, 1997;291-8.
29. Kaur A, Di Mascio M, Barabasz A, Rosenzweig M, McClure HM, Perelson AS, Ribeiro RM, Johnson RP: Dynamics of T- and B-lymphocyte turnover in a natural host of simian immunodeficiency virus. J Virol 2008; 82:1084-93.
30. Kraft Z, Derby NR, McCaffrey RA, Niec R, Blay WM, Haigwood NL, Moysi E, Saunders CJ, Wrin T, Petropoulos CJ, McElrath MJ, Stamatatos L: Macaques infected with a CCR5-tropic simian/human immunodeficiency virus (SHIV) develop broadly reactive anti-HIV neutralizing antibodies. J Virol 2007; 81:6402-11.
31. Kuller L, Benveniste RE, Tsai CC, Clark EA, Polacino P, Watanabe R, Overbaugh J, Katze MG, Morton WR: Intrarectal inoculation of macaques by the simian immunodeficiency virus, SIVmne E11S: CD4+ depletion and AIDS. J Med Primatol 1994; 23:397-409.
32. Lackner AA, Veazey RS: Current concepts in AIDS pathogenesis: Insights from the SIV/macaque model. Ann Rev Med 2007; 58:461-76.
33. Ling B, Veazey RS, Luckay A, Penedo C, Xu K, Lifson JD, Marx PA: SIV(mac) pathogenesis in rhesus macaques of Chinese and Indian origin compared with primary HIV infections in humans. AIDS 2002; 16:1489-96.
34. Lu Y, Pauza CD, Lu X, Montefiori DC, Miller CJ: Rhesus macaques that become systemically infected with pathogenic SHIV 89.6-PD after intravenous, rectal, or vaginal inoculation and fail to make an antiviral antibody response rapidly develop AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 19:6-18.
35. Marthas ML, Lu D, Penedo MC, Hendrickx AG, Miller CJ: Titration of an SIVmac251 stock by vaginal inoculation of Indian and Chinese origin rhesus macaques: Transmission efficiency, viral loads, and antibody responses. AIDS Res Hum Retroviruses 2001; 10; 17(15):1455-66.
36. Mattapallil JJ, Douek DC, Hill B, Nishimura Y, Martin M, Roederer M: Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 2005; 434:1093-7.
37. McClure J, Schmidt A, Rey-Cuille MA, Bannink J, Misher L, Tsai CC, Anderson D, Morton WR, Hu S-L: Derivation and characterization of a highly pathogenic isolate of human immunodeficiency virus type 2 that causes rapid CD4+ cell depletion in Macaca nemestrina. J Med Primatol 2000; 29: 114-26.
38. Miller CJ, McChesney MB, Lu X, Dailey PJ, Chutkowski C, Lu D, Brosio P, Roberts B, Lu Y: Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239. J Virol 1997; 71:1911-21.
39. Miller CJ, Marthas M, Greenier J, Lu D, Dailey PJ, Lu Y: In vivo replication capacity rather than in vitro macrophage tropism predicts efficiency of vaginal transmission of simian immunodeficiency virus or simian/human immunodeficiency virus in rhesus macaques. J Virol 1998; 72:3248-58.
40. Milush JM, Reeves JD, Gordon SN, Zhou D, Muthukumar A, Kosub DA, Chacko E, Giavedoni LD, Ibegbu CC, Cole KS, Miamidian JL, Paiardini M, Barry AP, Staprans SI, Silvestri G, Sodora DL: Virally induced CD4+ T cell depletion is not sufficient to induce AIDS in a natural host. J Immunol 2007; 179:3047-56.
41. O'Connor DH, Mothe BR, Weinfurter JT, Fuenger S, Rehrauer WM, Jing P, Rudersdorf RR, Liebl ME, Krebs K, Vasquez J, Dodds E, Loffredo J, Martin S, McDermott AB, Allen TM, Wang C, Doxiadis GG, Montefiori DC, Hughes A, Burton DR, Allison DB, Wolinsky SM, Bontrop R, Picker LJ, Watkins DI: Major histocompatibility complex class I alleles associated with slow simian immunodeficiency virus disease progression bind epitopes recognized by dominant acute-phase cytotoxic-T-lymphocyte responses. J Virol 2003; 77:9029-40.
42. Okoye A, Meier-Schellersheim M, Brenchley JM, Hagen SI, Walker JM, Rohankhedkar M, Lum R, Edgar JB, Planer SL, Legasse A, Sylwester AW, Piatak M Jr, Lifson JD, Maino, VC Sodora DL, Douek DC, Axthelm MK, Grossman Z, Picker LJ: Progressive CD4+ central memory T cell decline results in CD4+ effector memory insufficiency and overt disease in chronic SIV infection. J Exp Med 2007; 204:2171-85.
43. Otten RA, Brown BG, Simon M, Lupo LD, Parekh BS, Lairmore MD, Schable CA, Schochetman G, Rayfield MA: Differential replication and pathogenic effects of HIV-1 and HIV-2 in Macaca nemestrina. AIDS 1994; 8:297-306.
44. Pandrea I, Apetrei C, Gordon S, Barbercheck J, Dufour J, Bohm R, Sumpter B, Roques P, Marx PA, Hirsch VM, Kaur A, Lackner AA, Veazey RS, Silvestri G: Paucity of CD4+CCR5+ T cells is a typical feature of natural SIV hosts. Blood 2007; 109:1069-76.
45. Pandrea I, Onanga R, Souquiere S, Mouinga-Ondeme A, Bourry O, Makuwa M, Rouquet P, Silvestri G, Simon F, Roques P, Apetrei C: Paucity of CD4+ CCR5+ T cells may prevent transmission of simian immunodeficiency virus in natural nonhuman primate hosts by breast-feeding. J Virol 2008; 82:5501-9.
46. Polacino P, Cleveland B, Zhu YD, Kimata JT, Overbaugh J, Anderson D, Hu S-L: Immunogenicity and protective efficacy of Gag/Pol/Env vaccines derived from temporal isolates of SIVmne against cognate virus challenge. J Med Primatol 2007; 36:254-65.
47. Raffatellu M, Santos RL, Verhoeven DE, George MD, Wilson RP, Winter SE, Godinez I, Sankaran S, Paixao TA, Gordon MA, Kolls JK, Dandekar S, Baumler AJ: Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat Med 2008; 14:421-8.
48. Reimann KA, Parker RA, Seaman MS, Beaudry K, Beddall M, Peterson L, Williams KC, Veazey RS, Montefiori DC, Mascola JR, Nabel GJ, Letvin NL: Pathogenicity of simian-human immunodeficiency virus SHIV-89.6P and SIVmac is attenuated in cynomolgus macaques and associated with early T-lymphocyte responses. J Virol 2005; 79:8878-85.
49. Romano JW, Shurtliff RN, Dobratz E, Gibson A, Hickman K, Markham PD, Pal R: Quantitative evaluation of simian immunodeficiency virus infection using NASBA technology. J Virol Methods 2000; 86:61-70.
50. Rosenberg YJ, White BD, Papermaster SF, Zack P, Jahrling PB, Eddy GA, Burke DS, Lewis MG: Variation in T-lymphocyte activation and susceptibility to SIVPBj-14-induced acute death in macaques. J Med Primatol 1991; 20:206-10.
51. Ruprecht RM, Baba TW, Rasmussen R, Hu Y, Sharma PL: Murine and simian retrovirus models: The threshold hypothesis. AIDS 1996; 10:S33-40.
52. Staprans SI, Feinberg MB: The roles of nonhuman primates in the preclinical evaluation of candidate AIDS vaccines. Expert Rev Vaccines 2004; 3: S5-32.
53. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, Sodroski J: The cytoplasmic body component TRIM5[alpha] restricts HIV-1 infection in old world monkeys. Nature 2004; 427: 848-53.
54. Suryanarayana K, Wiltrout TA, Vasquez GM, Hirsch VM, Lifson JD: Plasma SIV RNA viral load determination by real-time quantification of product generation in reverse transcriptase-polymerase chain reaction. AIDS Res Hum Retroviruses 1988; 14:183-9.
55. ten Haaft P, Almond N, Biberfeld G, Cafaro A, Cranage MP, Ensoli B, Hunsmann G, Polyanskaya N, Stahl-Hennig C, Thorstensson R, Titti F, Heeney J: Comparison of early plasma RNA loads in different macaque species and the impact of different routes of exposure on SIV/SHIV infection. J Med Primatol 2001; 30:207-14.
56. Tosi AJ, Morales JC, Melnick DJ: Comparison of Y chromosome and mtDNA phylogenies leads to unique inferences of macaque evolutionary history. Mol Phylogenet Evol 2000; 17:133-44.
57. Veazey RS, DeMaria M, Chalifoux LV, Shvetz DE, Pauley DR, Knight HL, Rosenzweig M, Johnson RP, Desrosiers RC, Lackner AA: Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 1998; 280:427-31.
58. Vlasak J, Ruprecht RM: AIDS vaccine development and challenge viruses: getting real. AIDS 2006; 20:2135-40.
59. Xu R, Srivastava IK, Kuller L, Zarkikh I, Kraft Z, Fagrouch Z, Letvin NL, Heeney JL, Barnett SW, Stamatatos L: Immunization with HIV-1 SF162-derived Envelope gp140 proteins does not protect macaques from heterologous simian-human immunodeficiency virus SHIV89.6P infection. Virology 2006; 349:276-289.